Literature DB >> 8462598

von Willebrand factor storage requires intact prosequence cleavage site.

A M Journet1, S Saffaripour, E M Cramer, D Tenza, D D Wagner.   

Abstract

Large multimers of the adhesive glycoprotein von Willebrand factor (vWf) are stored in endothelial cells in rod-shaped granules called Weibel-Palade bodies, while small multimers are secreted constitutively. Expression of pro-vWf in other cells with a regulated pathway of secretion, results in formation of vWf-containing storage granules that have a morphology similar to Weibel-Palade bodies. vWf expressed without its prosequence is not stored. To evaluate the importance of prosequence cleavage in vWf storage, the Arg at position -1, known to be necessary for cleavage, was mutated to Gly. Transfection of this cleavage mutant into two cell lines with a regulated pathway of secretion (RIN 5F and AtT-20 cells) led to the formation of large multimers. However, treatment of the cell lysates by the enzyme endoglycosidase H (Endo-H) did not reveal significant amounts of intracellular Endo-H-resistant vWf, which indicates the absence of a pool of stored processed vWf. In addition, no Weibel-Palade body-like structure was detected in these cells by immunofluorescence labeling with anti-vWf antiserum. Electron microscopy and immunocytochemistry of RIN 5F cells expressing the pro-vWf mutant confirmed the absence of Weibel-Palade body-like structures. In addition, anti-vWf-linked gold particles were found in the ER, occasionally in rounded granules and particularly in lysosomal structures which were abundant. We conclude that the formation of large aggregates is not sufficient to induce efficient vWf storage, and that the lack of cleavage of the prosequence may direct the mutant pro-vWf molecule to a degradative pathway. Therefore, the prosequence cleavage is a requirement for vWf storage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462598

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  8 in total

Review 1.  Melanosomes--dark organelles enlighten endosomal membrane transport.

Authors:  Graça Raposo; Michael S Marks
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

2.  Electron tomography of early melanosomes: implications for melanogenesis and the generation of fibrillar amyloid sheets.

Authors:  Ilse Hurbain; Willie J C Geerts; Thomas Boudier; Sergio Marco; Arie J Verkleij; Michael S Marks; Graç Raposo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

Review 3.  Functional architecture of Weibel-Palade bodies.

Authors:  Karine M Valentijn; J Evan Sadler; Jack A Valentijn; Jan Voorberg; Jeroen Eikenboom
Journal:  Blood       Date:  2011-01-25       Impact factor: 22.113

4.  Intracellular trafficking of factor VIII to von Willebrand factor storage granules.

Authors:  J B Rosenberg; P A Foster; R J Kaufman; E A Vokac; M Moussalli; P A Kroner; R R Montgomery
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

5.  von Willebrand factor propeptide: biology and clinical utility.

Authors:  Sandra L Haberichter
Journal:  Blood       Date:  2015-07-27       Impact factor: 22.113

Review 6.  Lysosome-related organelles: driving post-Golgi compartments into specialisation.

Authors:  Graça Raposo; Michael S Marks; Daniel F Cutler
Journal:  Curr Opin Cell Biol       Date:  2007-07-12       Impact factor: 8.382

7.  An AP-1/clathrin coat plays a novel and essential role in forming the Weibel-Palade bodies of endothelial cells.

Authors:  Winnie W Y Lui-Roberts; Lucy M Collinson; Lindsay J Hewlett; Grégoire Michaux; Daniel F Cutler
Journal:  J Cell Biol       Date:  2005-08-08       Impact factor: 10.539

8.  Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis.

Authors:  Joanne F Berson; Alexander C Theos; Dawn C Harper; Danielle Tenza; Graça Raposo; Michael S Marks
Journal:  J Cell Biol       Date:  2003-05-05       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.